These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39224774)

  • 1. Validating a composite endpoint for acceptability evaluation of oral drug formulations in the pediatric population: a randomized, open-label, single dose, cross-over study.
    Münch J; Schwarzwälder AL; Kloft C; Bosse HM; Wargenau M; Reidemeister S; Klingmann I; Klingmann V
    Front Pharmacol; 2024; 15():1436554. PubMed ID: 39224774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of small-sized oblong tablets in comparison to syrup and mini-tablets in infants and toddlers: A randomized controlled trial.
    Münch J; Meissner T; Mayatepek E; Wargenau M; Breitkreutz J; Bosse HM; Klingmann V
    Eur J Pharm Biopharm; 2021 Sep; 166():126-134. PubMed ID: 34153451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the Acceptability, Swallowability, and Palatability of Film-Coated Mini-Tablet Formulation in Young Children: Results from an Open-Label, Single-Dose, Cross-Over Study.
    Münch J; Sessler I; Bosse HM; Wargenau M; Dreesen JD; Loforese G; Webb NJA; Sivasubramanian R; Reidemeister S; Lustenberger P; Klingmann V
    Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Composite Endpoint for Acceptability Evaluation of Oral Drug Formulations in the Pediatric Population.
    Wargenau M; Reidemeister S; Klingmann I; Klingmann V
    Ther Innov Regul Sci; 2022 Nov; 56(6):903-909. PubMed ID: 35471561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability, Swallowability, Palatability, and Safety of Multiple Film-Coated Mini-Tablets in Children Aged ≥2-<7 Years: Results of an Open-Label Randomised Study.
    Münch J; Kloft C; Farhan M; Fishman V; Leng S; Bosse HM; Klingmann V
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of an orodispersible film compared to syrup in neonates and infants: A randomized controlled trial.
    Klingmann V; Pohly CE; Meissner T; Mayatepek E; Möltner A; Flunkert K; Breitkreutz J; Bosse HM
    Eur J Pharm Biopharm; 2020 Jun; 151():239-245. PubMed ID: 32348882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of Multiple Uncoated Minitablets in Infants and Toddlers: A Randomized Controlled Trial.
    Klingmann V; Linderskamp H; Meissner T; Mayatepek E; Moeltner A; Breitkreutz J; Bosse HM
    J Pediatr; 2018 Oct; 201():202-207.e1. PubMed ID: 29960767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young patients' involvement in a composite endpoint method development on acceptability for paediatric oral dosage forms.
    Reidemeister S; Nafria Escalera B; Marín D; Balayla J; Klingmann I; Klingmann V
    Res Involv Engagem; 2023 Nov; 9(1):108. PubMed ID: 38031172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability of multiple coated mini-tablets in comparison to syrup in infants and toddlers: a randomised controlled study.
    Klingmann V; Hinder M; Langenickel TH; Chen F; Khder Y; Breitkreutz J; Bosse HM
    Arch Dis Child; 2023 Sep; 108(9):730-735. PubMed ID: 36963813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability of Uncoated Mini-Tablets in Neonates--A Randomized Controlled Trial.
    Klingmann V; Seitz A; Meissner T; Breitkreutz J; Moeltner A; Bosse HM
    J Pediatr; 2015 Oct; 167(4):893-896.e2. PubMed ID: 26259675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of swallowability and acceptability of scored darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) fixed-dose combination (FDC) tablets in HIV-1-infected children aged ≥6 to <12 years, using matching placebo tablets: A randomized study.
    Van Hemelryck S; Van Landuyt E; Hufkens V; Vanveggel S
    Antivir Ther; 2024 Apr; 29(2):13596535241248282. PubMed ID: 38725258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable acceptance of mini-tablets compared with syrup: a randomized controlled trial in infants and preschool children.
    Klingmann V; Spomer N; Lerch C; Stoltenberg I; Frömke C; Bosse HM; Breitkreutz J; Meissner T
    J Pediatr; 2013 Dec; 163(6):1728-1732.e1. PubMed ID: 23972645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Questionnaire Study to Investigate the Preferences of Children, Parents, and Healthcare Professionals for Different Formulations of Oral Medicinal Products.
    Wargenau M; Baase F; Eckardt K; Spitzhorn LS; Reidemeister S; Klingmann I; Klingmann V
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of swallowability and palatability of oral dosage forms in children: Report from an M-CERSI pediatric formulation workshop.
    Ternik R; Liu F; Bartlett JA; Khong YM; Thiam Tan DC; Dixit T; Wang S; Galella EA; Gao Z; Klein S
    Int J Pharm; 2018 Feb; 536(2):570-581. PubMed ID: 28844897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of Mini-Tablets in Young Children: Results from Three Prospective Cross-over Studies.
    Klingmann V
    AAPS PharmSciTech; 2017 Feb; 18(2):263-266. PubMed ID: 27714698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications.
    Freerks L; Sommerfeldt J; Löper PC; Klein S
    Eur J Pharm Biopharm; 2020 Nov; 156():11-19. PubMed ID: 32871197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-Analytical Framework to Assess the In Vitro Swallowability of Solid Oral Dosage Forms Targeting Patient Acceptability and Adherence.
    Ershad AL; Rajabi-Siahboomi A; Missaghi S; Kirby D; Mohammed AR
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33808875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient Acceptability and Preferences for Solid Oral Dosage Form Drug Product Attributes: A Scoping Review.
    Hauber B; Hand MV; Hancock BC; Zarrella J; Harding L; Ogden-Barker M; Antipas AS; Watt SJ
    Patient Prefer Adherence; 2024; 18():1281-1297. PubMed ID: 38919378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Tablet Size and Shape on the Swallowability in Older Adults.
    Hummler H; Stillhart C; Meilicke L; Grimm M; Krause E; Mannaa M; Gollasch M; Weitschies W; Page S
    Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.